Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2021-03-24 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議發放股利事宜
Notice of Dividend Amount Classification · 100% confidence The document is a company announcement regarding the board of directors' resolution to distribute dividends, including details on cash dividends and stock dividends for the fiscal year 109 (2020). It specifies dividend amounts per share, total cash dividend amount, and stock dividend shares. The document is short (787 characters) and focuses solely on dividend distribution details without containing full financial statements or comprehensive financial analysis. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2021-03-24 Chinese
109年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 95% confidence The document contains detailed information about dividend distribution, including dates of board resolutions and shareholder meetings, dividend amounts per share, and related company policies. It includes tables with dividend allocation details and explanations of dividend policies and legal references. The content is focused on dividend amounts, payment dates, and shareholder distribution details, which aligns with the definition of a Notice of Dividend Amount (DIV). The document length is under 5,000 characters and is not merely an announcement of a report but provides substantive dividend distribution data. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2021-03-24 Chinese
公告本公司110年召開股東常會相關事宜。
AGM Information Classification · 95% confidence The document is a public announcement from a listed company (4119 旭富) regarding the scheduling and agenda of its upcoming Annual General Meeting (AGM) for the year 110 (Taiwan calendar, corresponding to 2021). It details the date, location, and items to be discussed at the AGM, including reports, approvals, and amendments to company rules. There is no financial data or detailed report content included, only the announcement of the AGM and its agenda. The document length is short (935 characters), and it serves as an announcement rather than the actual AGM materials or reports. Therefore, it fits the category of AGM Information (AGM-R).
2021-03-24 Chinese
公告本公司109年財務合併報告提報董事會。
Annual Report Classification · 95% confidence The document is a financial announcement from a company (4119 旭富) reporting its consolidated financial results for the fiscal year 109 (which corresponds to 2020 in the Gregorian calendar). It includes detailed financial figures such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity as of the end of the period. The document states that the financial report was submitted to the board and approved by the audit committee on 110/03/24 (March 24, 2021). The length of the document is short (905 characters) but it contains substantive financial data and analysis for a full fiscal year. This matches the characteristics of an Annual Report (10-K) or a similar comprehensive yearly financial report. However, since it is a financial report for the full fiscal year with detailed financial data, it fits best under the Annual Report (10-K) category rather than a simple announcement or regulatory filing. Therefore, the classification is 10-K with high confidence.
2021-03-24 Chinese
本公司委託同業協助生產一項原料藥。
Regulatory Filings Classification · 95% confidence The document is a short announcement (798 characters) from a listed company (4119 旭富) disclosing a contract to outsource production of a raw material drug to another company. It includes details such as contract dates, parties involved, and impact on business. There is no financial statement, no detailed report, no earnings data, or management discussion. The document is a regulatory disclosure about a business contract, fitting the category of a general regulatory announcement. It is not a full report, earnings release, or management report. Therefore, it fits best under Regulatory Filings (RNS).
2021-03-18 Chinese
依據臺證上一字第1091806531號函辦理及補充說明。
Regulatory Filings Classification · 95% confidence The document is a short announcement (796 characters) from a listed company (旭富製藥科技股份有限公司) providing supplementary information in response to a regulatory letter (臺證上一字第1091806531號函). It includes financial data as of February 28, 110 (Taiwan calendar year), such as cash, financial assets, and short-term borrowings, but it is not a full financial report. The document is a regulatory compliance update or clarification rather than a full report like an Annual Report or Interim Report. It does not contain comprehensive financial statements or detailed analysis. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement that does not fit other specific categories and is relatively short, serving as a compliance disclosure.
2021-03-18 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.